4.8 Article

Microbial genetic and transcriptional contributions to oxalate degradation by the gut microbiota in health and disease

Journal

ELIFE
Volume 10, Issue -, Pages -

Publisher

eLIFE SCIENCES PUBL LTD
DOI: 10.7554/eLife.63642

Keywords

-

Categories

Funding

  1. National Institute of Allergy and Infectious Diseases (NIAID) [U01AI22285]
  2. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01DK110014]
  3. Rare Kidney Stone Consortium [U54 DK083908]
  4. The C & D and Zlinkoff Funds
  5. Oxalosis and Hyperoxaluria career development grant
  6. TransAtlantic Partnership of the Fondation

Ask authors/readers for more resources

The human microbiota primarily uses type II oxalate degradation pathways, with the oxalate autotroph Oxalobacter formigenes dominating this function. Patients with inflammatory bowel disease show elevated enteric oxalate levels and reduced microbiota ODP expression, potentially contributing to disrupted oxalate homeostasis. Colonization of mice with O. formigenes leads to significant reduction in host fecal and urine oxalate levels, supporting the importance of the microbiome in host oxalate homeostasis.
Over-accumulation of oxalate in humans may lead to nephrolithiasis and nephrocalcinosis. Humans lack endogenous oxalate degradation pathways (ODP), but intestinal microbes can degrade oxalate using multiple ODPs and protect against its absorption. The exact oxalate-degrading taxa in the human microbiota and their ODP have not been described. We leverage multi-omics data (>3000 samples from >1000 subjects) to show that the human microbiota primarily uses the type II ODP, rather than type I. Furthermore, among the diverse ODP-encoding microbes, an oxalate autotroph, Oxalobacter formigenes, dominates this function transcriptionally. Patients with inflammatory bowel disease (IBD) frequently suffer from disrupted oxalate homeostasis and calcium oxalate nephrolithiasis. We show that the enteric oxalate level is elevated in IBD patients, with highest levels in Crohn's disease (CD) patients with both ileal and colonic involvement consistent with known nephrolithiasis risk. We show that the microbiota ODP expression is reduced in IBD patients, which may contribute to the disrupted oxalate homeostasis. The specific changes in ODP expression by several important taxa suggest that they play distinct roles in IBD-induced nephrolithiasis risk. Lastly, we colonize mice that are maintained in the gnotobiotic facility with O. formigenes, using either a laboratory isolate or an isolate we cultured from human stools, and observed a significant reduction in host fecal and urine oxalate levels, supporting our in silico prediction of the importance of the microbiome, particularly O. formigenes in host oxalate homeostasis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available